Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
일요일, 9월 06

IQVIA Holdings Inc

IQVNYSE
Trade with Public
Trade with Public
$267.77
-3.85-1.42%
가까이에: Sep 4, 5:00 PM EST
$267.77
N/A
시간외: Sep 4, 4:15 PM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

IQVIA Holdings Financials

IQVIA Holdings (IQV) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
IQVIA Hldgs Q2 Adj. EPS $3.15 Beats $3.03 Estimate, Sales $4.368B Beat $4.301B Estimate

IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $3.15 per share which beat the analyst consensus estimate of $3.03 by 3.96 percent. This is a 12.1 percent increase over earnings of $2.81 per share from the same
Benzinga Newsdesk

PRO
IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 Est; Raises FY2026 Sales Guidance from $17.150B-$17.350B to $17.275B-$17.475B vs $17.286B Est

IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.65-$12.95 to $12.80-$13.00 vs $12.80 analyst estimate. Raises FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.275 billion-$17.475
Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

PRO
IQVIA Holdings Raises FY2026 Adj EPS Guidance from $12.55-$12.85 to $12.65-$12.95 vs $12.71 Est; Affirms FY2026 Sales Guidance of $17.150B-$17.350B vs $17.241B Est.

IQVIA Holdings (NYSE:IQV) raises FY2026 Adj EPS guidance from $12.55-$12.85 to $12.65-$12.95 vs $12.71 analyst estimate. Affirms FY2026 sales outlook from $17.150 billion-$17.350 billion to $17.150 billion-$17.350
Benzinga Newsdesk

PRO
IQVIA Hldgs Q1 Adj. EPS $2.90 Beats $2.82 Estimate, Sales $4.151B Beat $4.100B Estimate.

IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $2.90 per share which beat the analyst consensus estimate of $2.82 by 2.84 percent. This is a 7.41 percent increase over earnings of $2.70 per share from the same
Benzinga Newsdesk

Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans

Charles River to sell CDMO, Cell Solutions, and European assets, raise 2026 earnings outlook as shares trade near 52-week lows.
Vandana Singh

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved